Eghbali M, Alaei-Shahmiri F, Hashemi-Madani N, Emami Z, Mostafavi L, Malek M, Khamseh ME (2024) Glucagon-like peptide 1 (GLP-1) receptor variants and glycemic response to liraglutide: a pharmacogenetics study in Iranian people with type 2 diabetes mellitus
For B12 deficiency treatment , medical professionals may recommend injections: Every few days for the first 12 weeks
Notably, these findings align with AKT1s well-established role in regulating glycolysis, glucose uptake, and TCA cycle flux via downstream effectors such as mTOR, GSK3, and FOXO1 [51,52,53]
doi: 10.1007/s10535-015-0542-x
While the study cannot establish causation, investigators say the results provide a strong rationale for prospective clinical trials evaluating whether GLP-1 drugs could become part of future breast cancer prevention strategies
Starting Combination Therapy: What to Expect Initiating combination therapy with GLP-1 receptor agonists and SGLT2 inhibitors requires careful planning, patient education, and appropriate monitoring to optimise outcomes and minimise adverse effects
